Rankings
▼
Calendar
HROW FY 2025 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena
HROW
Harrow Health, Inc.
$1B
FY 2025 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$272M
+36.4% YoY
Gross Profit
$204M
75.1% margin
Operating Income
$31M
11.2% margin
Net Income
-$5M
-1.9% margin
EPS (Diluted)
$-0.14
Cash Flow
Operating Cash Flow
$44M
Free Cash Flow
$43M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$399M
Total Liabilities
$347M
Stockholders' Equity
$52M
Cash & Equivalents
$73M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$272M
$200M
+36.4%
Gross Profit
$204M
$150M
+35.9%
Operating Income
$31M
$9M
+245.9%
Net Income
-$5M
-$17M
+70.6%
← Q4 2024
All Quarters
Q1 2025 →